|
|
Prescribing Information
The information provided herein is solely for use by physicians and healthcare professionals in the United States. The products listed may not have been approved in other countries and may not be available everywhere. » Transplant Medicine » Coagulation » Critical Care & Immunology » Alpha-1
Transplant Medicine
| | CytoGam® Cytomegalovirus Immune Globulin Intravenous (HUMAN)(CMV-IGIV)
Full Prescribing Information for Cytogam® |
Coagulation
|
Helixate® FS
Antihemophilic Factor (Recombinant) Formulated with Sucrose
Full Prescribing Information for Helixate® FS |
|
Humate-P®
Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried,
Pasteurized
Full Prescribing Information for Humate-P® |
|
Monoclate-P®
Antihemophilic Factor (Human) Factor VIII:C Pasteurized Monoclonal
Antibody Purified
Full Prescribing Information for Monoclate-P® |
|
Mononine®
Coagulation Factor IX (Human) Monoclonal Antibody Purified
Full Prescribing Information for Mononine® |
|
Stimate®
(Desmopressin acetate) Nasal Spray, 1.5 mg/mL.
Full Prescribing Information for Stimate®
How to Purchase Stimate® |
Critical Care & Immunology
Critical Care
|
AlbuRx® 5, AlbuRx® 25
Albumin (Human) 5% Solution and 25% Solution
Full Prescribing Information for AlbuRx® 5
Full Prescribing Information for Albuminar® 25 |
|
Albuminar® 25
Albumin (Human) USP, 25%
Full Prescribing Information for Albuminar®-25 |
Immune Mediated Disorders
|
Privigen®
Immune Globulin Intravenous (Human) 10%
NEW Privigen® is an intravenous immunoglobulin (IVIg) that was approved by the FDA in July 2007.
Warning: Immune Globulin Intravenous (Human) (IGIV) products have been reported to be associated with renal dysfunction, acute renal failure, osmotic nephrosis, and death. See boxed warning and the PRECAUTIONS and DOSAGE AND ADMINISTRATION section of full Prescribing information for important information intended to reduce the risk of acute renal failure.
Full prescribing information for Privigen® |
|
Carimune® NF Nanofiltered
Immune Globulin Intravenous (Human) Warning: Immune Globulin
Intravenous (Human) (IGIV) products have been reported to be associated
with renal dysfunction, acute renal failure, osmotic nephrosis, and death.
See boxed warning and the PRECAUTIONS and DOSAGE AND
ADMINISTRATION section of full important information intended to
reduce the risk of acute renal failure.
Full Prescribing Information for Carimune® NF Nanofiltered |
|
Vivaglobin®
Immune Globulin Subcutaneous (Human)
Full Prescribing Information for Vivaglobin®
Full Patient Prescribing Information for Vivaglobin® |
Rh Immunoprophylaxis
|
Rhophylac®
Rho(D) Immune Globulin Intravenous (Human)
Full Prescribing Information for Rhophylac® |
Alpha-1
|
Zemaira®
Alpha1-Proteinase Inhibitor (Human)
Full Prescribing Information for Zemaira®
|
|